Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123337) titled 'Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis' on Aug. 7.

Study Type: Observational

Primary Sponsor: University of Zintan

Condition: Multiple Sclerosis

Recruitment Status: Not recruiting

Date of First Enrollment: August 1, 2023

Target Sample Size: 369

Countries of Recruitment: Libyan Arab Jamahiriya

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07123337

Published by HT Digital Content Services with permission from Health Daily Digest....